Matches in DBpedia 2014 for { <http://dbpedia.org/resource/WAY-161503> ?p ?o. }
Showing items 1 to 25 of
25
with 100 items per page.
- WAY-161503 abstract "WAY-161503 is a full agonist at the serotonin 5-HT2B and 5-HT2C receptors. Administration of WAY-161503 decreased food intake in rats, an effect mediated by its action on the 5-HT2C receptors. In addition, there was no development of tolerance with up to 15 days of treatment. However, clinical utility of WAY-161,503 may be limited as activation of the 5-HT2B receptor has been linked to pulmonary hypertension and cardiac valve problems.".
- WAY-161503 iupacName "(R)-8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one".
- WAY-161503 thumbnail WAY-161503.svg?width=300.
- WAY-161503 wikiPageID "34119748".
- WAY-161503 wikiPageRevisionID "593301356".
- WAY-161503 hasPhotoCollection WAY-161503.
- WAY-161503 imagefile "WAY-161503.svg".
- WAY-161503 imagesize "200".
- WAY-161503 iupacname "-89".
- WAY-161503 subject Category:Anorectics.
- WAY-161503 subject Category:Lactams.
- WAY-161503 subject Category:Organochlorides.
- WAY-161503 subject Category:Serotonin_receptor_agonists.
- WAY-161503 type ChemicalCompound.
- WAY-161503 type ChemicalSubstance.
- WAY-161503 type ChemicalObject.
- WAY-161503 type Thing.
- WAY-161503 comment "WAY-161503 is a full agonist at the serotonin 5-HT2B and 5-HT2C receptors. Administration of WAY-161503 decreased food intake in rats, an effect mediated by its action on the 5-HT2C receptors. In addition, there was no development of tolerance with up to 15 days of treatment. However, clinical utility of WAY-161,503 may be limited as activation of the 5-HT2B receptor has been linked to pulmonary hypertension and cardiac valve problems.".
- WAY-161503 label "WAY-161503".
- WAY-161503 sameAs m.0hq_6vv.
- WAY-161503 sameAs Q7946880.
- WAY-161503 sameAs Q7946880.
- WAY-161503 wasDerivedFrom WAY-161503?oldid=593301356.
- WAY-161503 depiction WAY-161503.svg.
- WAY-161503 isPrimaryTopicOf WAY-161503.
